Last night, CBC TV’s The National introduced its audience to a novel clinical trial currently underway in Canada. The trial has been partially enabled by support from BioCanRx to manufacture the engineered viruses being given to the study’s participants. The clinical trial is testing a new investigational therapy called oncolytic virus immunotherapy, which… Read more »
Tag: Brian Lichty
BioCanRx investigators receive $5M to develop virus therapy for prostate cancer
News item Prostate Cancer Canada and the Movember Foundation have partnered to award $5 million to 2020 to a multi-disciplinary team of scientists and clinicians led by BioCanRx Scientific Director, Dr. John Bell. The team is mainly composed of BioCanRx network investigators who are working together to develop a treatment specifically for prostate cancer… Read more »
Cancer patients treated in world-first clinical trial of Canadian viral therapy
Clinical Trials, Media release Canadian researchers have launched the world’s first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and… Read more »
